Real-World Experience with Cangrelor as Adjuvant to Percutaneous Coronary Intervention: A Single-Centre Observational Study

Real-World Experience with Cangrelor as Adjuvant to Percutaneous Coronary Intervention: A Single-Centre Observational Study

Background. Reversible P2Y12 inhibition can be obtained with cangrelor administered intravenously. More experience with cangrelor use in acute PCI with unknown bleeding risk is needed. Objectives. To describe real-world use of cangrelor including patient and procedure characteristics and patient out...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Troels Thim, Lars Jakobsen, Rebekka Vibjerg Jensen, Nicolaj Støttrup, Ashkan Eftekhari, Erik Lerkevang Grove, Sanne Bøjet Larsen, Jacob Thorsted Sørensen, Steen Carstensen, Sahar Amiri, Karsten Tange Veien, Evald Høj Christiansen, Christian Juhl Terkelsen, Michael Maeng, Steen Dalby Kristensen
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Wiley 2023-01-01
Saila:Cardiology Research and Practice
Sarrera elektronikoa:http://dx.doi.org/10.1155/2023/3197512

Internet

http://dx.doi.org/10.1155/2023/3197512

Antzeko izenburuak